FindTrial
Sign In

A Cross-sectional Study to Estimate Seroprevalence of Dengue in Selected High, Medium, and Low Risk Regions in China

A Cross-sectional Study to Estimate Seroprevalence of Dengue in Selected High, Medium, and Low Risk Regions in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097684
Enrollment
Unknown
Registered
2025-02-24
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dengue fever

Interventions

Observation group:NA

Sponsors

Shandong Second Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 2 years old or above, residing locally for more than 6 months, possessing normal communication skills or obtaining unanimous consent from guardians, education and gender are not required.

Exclusion criteria

Exclusion criteria: Fever symptoms within 14 days I have participated in other studies on dengue fever of the same type Vaccinated against dengue fever There are serious chronic diseases that are not suitable for blood collection.

Design outcomes

Primary

MeasureTime frame
engue fever IGg antibody;—

Countries

China

Contacts

Public ContactQiyong Liu

Shandong Second Medical University

liuqiyong@icdc.cn+86 139 1059 9152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026